Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.
Ying, Weiwen, Zhenjian Du, Lijun Sun, Kevin P Foley, David A Proia, Ronald K Blackman, Dan Zhou, et al. 2012. “Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy.”. Molecular Cancer Therapeutics 11 (2): 475-84.